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Abstract 9 
Background and purpose: Current guidelines recognise the need for neonatal 10 
physiotherapists to provide surveillance assessments to neonates, from birth onwards. This 11 
study explored the current use, barriers and facilitators to using developmental outcomes 12 
measures in neonatal units, in the United Kingdom. 13 
 14 
Method: A cross-sectional, web-based survey with 32 items was piloted and distributed to 15 
members of the Association of Paediatric Chartered Physiotherapists and advertised on 16 
social media and professional discussion forums. Responses from the group of therapists 17 
who reported using outcome measures, were compared with those who reported not using 18 
them, using Mann-Whitney U tests for non-parametric data. Other findings were presented 19 
descriptively.  20 
 21 
Results: Forty-three completed surveys were analysed. Most respondents (91%) had a 22 
positive attitude towards the use of developmental outcome measures, and many (79%) 23 
used them in their neonatal practice. These included the General Movement Assessment 24 
(n=18/34), Hammersmith Neonatal Neurological Examination (n=16/34), and Lacey 25 
Assessment of Preterm Infants (n=15/34). The high cost of acquiring certain measures was 26 
a perceived barrier (86%). The presence of a neonatal-specialist physiotherapist (p=0.023), 27 
active engagement in continuous professional development (0.011) and support from fellow 28 
physiotherapists (p<0.001) significantly influenced outcome measure utilisation. 29 
  30 
Conclusion: Outcome measures were commonly used in the analysed units. Perceived 31 
utility and positive attitudes towards outcome measure use are in-line with current 32 
recommendations. This must be weighed up against the high acquisition cost of some 33 
measures. Further research is required to define tailored strategies for promoting best 34 





Approximately 60,000 babies are born prematurely (earlier than 37 weeks gestation), in the 38 
United Kingdom (UK) every year (Office of National Statistics, 2016). There has been 39 
continued improvement in the delivery of neonatal care that has enabled an increase in 40 
survival of infants born extremely prematurely between both 1995 and 2006, and still further 41 
between 2008 and 2014 (Santhakumaran et al, 2017). However, infants who survive a 42 
premature birth are at greater risk of developmental delay with associated long-term 43 
consequences, such as cerebral palsy (Moore et al, 2012). Physiotherapists play a vital role 44 
in the treatment of neonates in the UK, particularly those who are at increased risk of 45 
developmental delay. Input from a physiotherapist may include baseline assessment, 46 
parental education and working within the multi-disciplinary team to ensure that the complex 47 
needs of the family are being met. Guidelines published by the National Institute for Health 48 
and Care Excellence (NICE) on the developmental follow-up of children and young people 49 
born prematurely, recommended that premature babies are monitored for the first two years 50 
of their lives (NICE, 2017). Physiotherapists are well placed to contribute to this monitoring 51 
process.  52 
The physiotherapy assessment of neonates can provide an important baseline of 53 
information. This can then be used to monitor developmental evolution, identify 54 
abnormalities and predict developmental disabilities (Majnemer and Mazer, 1998). 55 
Therefore, the use of a valid, reliable, standardised tool has the potential to highlight those 56 
patients requiring early intervention, aid in decision-making processes regarding the 57 
management of the baby, and ensure optimal quality of care (CSP, 2012). However, the 58 
purpose of outcome measures in neonates varies widely, encompassing neurological, 59 
neurobehavioural and motor performance assessments. They also have different functions. 60 
These include predictive value (the ability to predict the likely future course of development), 61 
evaluation (change as a result of a specific intervention) and discriminative function (the 62 
ability to discriminate between the presence or absence of a certain impairment at a single 63 
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time-point). For these reasons, the utilisation of developmental outcome measures is likely to 64 
vary substantially between hospitals. This could be problematic when the infant is 65 
transferred between neonatal units, as 10% of hospitalised infants were in 2015 (RCPCH, 66 
2016). 67 
To date, no studies have investigated the current use of, or facilitators and barriers to, using 68 
outcome measures in neonatal care. A previous cross-sectional survey found that 89.1% 69 
from a sample of 97 physiotherapists used a standardised assessment tool during their 70 
neurodevelopmental follow-up programmes of neonates (Harniess and Nikopoulou-Smyrni, 71 
2015). The inclusion criteria for this particular work specified that ‘lead’ neonatal 72 
physiotherapists would be recruited, therefore it remains unknown whether ‘non-lead’ 73 
physiotherapists have a similar approach to the use of outcome measures. Furthermore, the 74 
study concentrated on follow-up assessment, leaving the broader use of outcome measures 75 
unknown.  76 
Although barriers to using outcome measures have been identified in some specialties of 77 
physiotherapy (Swinkels et al, 2011), the unique environment of neonatal care means that 78 
some of the challenges are likely to be specific to the assessment of neonates. It is vital that 79 
the use of outcome measures in the UK is quantified, to measure the extent to which best 80 
practice is currently being adhered to. Barriers should be identified so that strategies can be 81 
implemented to address them. ‘Facilitators’ (factors that enable or support therapists to 82 
utilise outcome measures), will provide researchers and clinicians with an understanding of 83 
how best to encourage others to utilise outcomes. Therefore, the aims of the study were 84 
threefold. Firstly, to capture a snapshot of current use of developmental outcome measures 85 
in neonatal care in the UK. Secondly, to identify any facilitators or barriers that supported or 86 
impeded their implementation. Thirdly, to describe differences in neonatal unit, or in attitudes 87 





Ethical approval was granted by the Chair of the UCL Research Ethics Committee on 6th 91 
June 2017 (REC reference 11151/001). UCL Data Protection and Risk Assessment 92 
registration was obtained on 26th May 2017 (reference no. Z6364106/2017/05/124). To 93 
prevent the occurrence of duplicate responses from the same hospital, participants were 94 
requested to provide demographic details of their units, which were coded to maintain 95 
anonymity in accordance with the Data Protection Act 1998. 96 
A survey was selected as the most appropriate method for meeting the aims of the study. It 97 
comprised of 32 items divided into three domains: the use of developmental outcome 98 
measures; barriers and facilitators to their implementation; neonatal physiotherapy service 99 
provision and training (Appendix 1). Inclusion criteria for completing the survey were 100 
physiotherapists working in neonatal care in the UK, with only one response permitted per 101 
hospital site.  102 
The survey included closed-ended multiple-choice questions, with additional free-text space 103 
for respondents to clarify their responses or add any options that were not listed (Polgar and 104 
Thomas, 2013). Perceived facilitators and barriers to implementation of outcome measures 105 
were gathered using a 5-point Likert scale, with responses ranging from ‘strongly disagree’ 106 
(1 point) to ‘strongly agree’ (5 points) in response to a range of statements. These 107 
statements were based on previous studies into the implementation of guidelines and 108 
outcome measures for general practitioners, midwives and physiotherapists (Peters et al., 109 
2003, Van der Wees et al., 2013, Van Peppen et al., 2008). The final section of the survey 110 
was adapted from a validated questionnaire published in 2012, the aim of which was to 111 
establish a benchmark for the overall provision of neonatal physiotherapy services in the UK 112 
(Ronan and Barron, 2012). With permission from the principal author, eight questions from 113 
that questionnaire were utilised in the current study, in order to gather data regarding 114 
neonatal units, levels of expertise and training. 115 
The questionnaire was piloted among two specialist neonatal physiotherapists who were 116 
independent of the study, and three members of UCL academic staff. This helped to identify 117 
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ambiguous questions, and any perceived biased or leading questions. The participants of 118 
the pilot study were also asked to email their comments regarding the time taken to 119 
complete the survey and the clarity, relevance and completeness of the survey in order to 120 
evaluate its face and content validity (Polgar and Thomas, 2013). Three items were added 121 
(items 14, 18 and 19, see Appendix 1) and details within the survey, in particular the order of 122 
the domains and the phrasing of the questions were modified. One specific point raised by 123 
all reviewers related to the frequent use of ‘negative sentences’ such as, ‘the use of the 124 
developmental outcome measures is not too time-consuming.’ Although reverse worded 125 
items have been shown to reduce response bias, recent evidence suggests that they are 126 
more likely to result in confusion (Sonderen et al, 2013). The reviewers also had differing 127 
opinions over how to respond to such questions. Therefore, for clarity, these were re-128 
phrased to provide consistently positively-worded items.  129 
The finalised electronic survey was distributed along with an invitation to all members of the 130 
APCP. Respondents were also sought using social media (Twitter and Facebook) and via 131 
on-line professional discussion forums (i-CSP) in order to reach other neonatal 132 
physiotherapists who were not members of the APCP. Data collection was conducted using 133 
the UCL Opinio web-based survey tool, and all responses were anonymised at source. Data 134 
were transferred from the Opinio software into an Excel spreadsheet for storage, which 135 
allowed data transfer into Statistical Package for the Social Sciences (SPSS) software for 136 
statistical analysis. Descriptive statistics were used to report the findings. Furthermore, 137 
responses from the group of therapists who reported using outcome measures, were 138 
compared with those who reported not using them, using Mann-Whitney U tests for non-139 
parametric data and presented as U and p-values. This was important, since one aim of the 140 
survey was to compare differences between users and non-users in their attitudes and 141 
approaches towards outcome measures. Where questions were binary (requiring a ‘yes’ or 142 
‘no’ response), responses were compared using Fisher’s exact test after dividing the 143 
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respondents into those who reported using outcome measures and those who reported not 144 
using them.  145 
Results 146 
A total of 91 responses were received, from which 43 were included in this study. 147 
Respondents of the 47 remaining questionnaires did not press the final ‘submit’ button, and 148 
their surveys were often substantially incomplete, so these were excluded. One other 149 
completed survey was excluded as the participant was not working in the UK. Each 150 
response came from a different hospital, so no hospital-specific focus of practice was over-151 
represented. Of the included surveys, 79.1% (n=34) of respondents reported using 152 
developmental outcome measures on their units (Table 1). 153 
Respondents were predominantly Band 7 physiotherapists (86%, n=37), working in units 154 
which had multiple bands of physiotherapy staff. All the units (100%, n=6) that included a 155 
Band 8 physiotherapist in their skill mix, used outcomes measures. This compares with 78% 156 
(n=29) of units where the highest level of experience was Band 7. Most of the respondents 157 
(44%) worked in units providing level 3 neonatal care, although 18 physiotherapists worked 158 
across more than one level of care. 90% of physiotherapists who worked on a unit that 159 
included level 3 care, used outcome measures. This compares with 67% of those whose 160 
highest level of care was level 2. Neither band of physiotherapists present on units nor level 161 
of care significantly influenced the use of outcome measures on the unit (U=132.5, p=0.513 162 
and U=110.5, p=0.177 respectively). 163 
Of the 43 units included in the study, 58.1% (n=25) had input from a neonatal-specialist 164 
physiotherapist. ‘Neonatal-specialist’ was a self-reported term to differentiate from 165 
physiotherapists who would normally work with either paediatrics or adult patients. Where a 166 
neonatal-specialist physiotherapist was involved on the neonatal unit, 92% (n=23/25) of the 167 
respondents reported using outcome measures (Table 1). The presence of a neonatal-168 
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specialist on the unit was significantly related to the use of outcome measures (Fisher’s 169 
exact test: p=0.023).  170 
Nearly all the respondents (n=40/43) participated in continuing professional development 171 
related to neonatal care. This included self-directed learning (90.7%) and peer learning and 172 
support within each NHS trust (81.4%) as part of their specialist training. 53% of 173 
physiotherapists also took part in postgraduate education with a neonatal component. The 174 
number of continuing professional development opportunities, training and support sources 175 
accessed by physiotherapists was significantly higher in the group who reported using 176 
outcome measures (U=71.5, p=0.011). 177 
Current use of outcome measures 178 
The most frequently utilised outcome measures were the Hammersmith Neonatal/Infant 179 
Neurological Examination (HNNE/HINE), the Lacey Assessment of Preterm Infants (LAPI) 180 
and the Prechtl’s Method of Qualitative Assessment of General Movements (GMs) (Table 2). 181 
Physiotherapists with greater years of experience in the use of developmental outcome 182 
measures, or who received specific training in their use were significantly more likely to 183 
utilise a measure on their unit (Table 1).  184 
Facilitators to using developmental outcome measures 185 
The majority of respondents (n=39/43, 91%) had a positive attitude towards the use of 186 
outcome measures in clinical practice (item 8, ‘I feel that I have a positive attitude towards 187 
the use of developmental outcome measures’). The same number of respondents 188 
recognised the utility of outcome measures in providing insight for parents into their child’s 189 
physical functioning (item 21) (Table 3). Indeed, four physiotherapists specified in the 190 
‘comments’ section that the use of outcome measures gave them the opportunity to have a 191 
discussion with the parents about different aspects of infant development, developmental 192 




Barriers to using developmental outcome measures 195 
Finding the opportune moment for completing a developmental assessment (item 18) was 196 
challenging for most of the physiotherapists (81.4%). Funding issues were reported by six 197 
respondents and were confirmed by 86.1% (n=37/43) of physiotherapists who considered 198 
the costs related to outcome measure acquisition (such as courses and materials) (item 16) 199 
an obstacle to using them, indicating the main barrier to their implementation (Table 3). 200 
 201 
Differences in perceived barriers and facilitators between respondents using, and not using, 202 
developmental outcome measures on units 203 
There were some significant differences between those respondents who used outcome 204 
measures and those who did not. There were significantly different responses to the 205 
statements ‘the use of a developmental outcome measure fits into my way of working at my 206 
unit’ (item 9) (U=18.5, p<0.001), and ‘I regard the use of a developmental outcome measure 207 
to be a good starting point for my physiotherapy interventions and for further referrals’ (item 208 
10) (U=46, p<0.001). Those who used outcome measures tended to agree with these 209 
statements (with the exception of one respondent), whereas those who didn’t tended to 210 
disagree or be neutral (Table 3). 211 
Regarding the outcome measures’ adaptability to the individual needs of infants (item 20), 212 
there was a significant difference between the two groups (U=79.5, p=0.016) and although 213 
73.5% of the physiotherapists who utilised outcome measures agreed with the statement 214 
(n=25/34), one reported the difficulty of using non-completed data when transferring patients 215 
between units and for longitudinal data collection. 216 
With regards to the environment, physiotherapists who had support from fellow 217 
physiotherapists (item 22) and other professionals (item 23) were significantly more likely to 218 
utilise outcome measures than those who did not (with U=34, p<0.001 and U=70, p=0.005 219 




Existing guidelines recognise the need for neonatal physiotherapists to provide surveillance 222 
assessments and developmental support to neonates, from birth to age of two years (NICE, 223 
2017; CSP, 2017). From the results gained, it is encouraging that developmental outcome 224 
measures were utilised by 79% of the 43 respondents to the survey, facilitating the majority 225 
of the surveyed physiotherapists to provide a good-quality physiotherapy service and 226 
appropriate follow-up (Grol and Grimshaw, 2003; King et al., 2011). The most frequently 227 
used outcome measures were HNNE/HINE, GMs and LAPI. This study found that the 228 
presence of a band 8 clinical specialist physiotherapist and/or input from a neonatal 229 
specialist physiotherapist on the unit, were significant indicators for the use of developmental 230 
outcome measures. Those physiotherapists who engaged with a variety of continuing 231 
professional developmental opportunities from a number of different sources were also more 232 
likely to use outcome measures in clinical practice. 233 
The most representative neonatal service care was level 3 (44%). Although there was no 234 
significant relationship between the level of care and the use of outcome measures, most 235 
physiotherapists working on a unit that included level 3 care used outcome measures 236 
(89.5%). This suggests that outcome measures hold particular clinical importance for infants 237 
with more complex conditions, who require closer monitoring and tend to have longer length 238 
of stay; thus, greater priority may be given to using outcome measures to monitor these 239 
infants.  240 
The band of physiotherapy staff most present on units was Band 7 (86%), which is aligned 241 
with the previous findings (72.8% n=43/59, without missing data), (Ronan and Barron, 2012). 242 
Again, despite no significant relationship being found between the band of physiotherapists 243 
present on the unit and outcome measures utilisation, all units that included a Band 8 244 
physiotherapist used outcome measures. This, combined with the findings regarding the use 245 
of outcome measures and involvement of a neonatal-specialist physiotherapist on the 246 
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neonatal unit (Fisher exact test: p=0.023), suggests that the presence of a clinical specialist 247 
results in close monitoring of neonates.  248 
Level and amount of training and support sources had a significant influence in outcome 249 
measure utilisation (higher levels of training and multiple training sources being related to 250 
outcome measure usage). These findings are in keeping with previous studies (Jette et al., 251 
2009; Wedge et al., 2012). However, previous studies also argue that physiotherapists with 252 
greater clinical expertise tended to use informal outcome measures, relying on their own 253 
judgement and experience, whilst newly graduated physiotherapists were more familiar with 254 
integrating standardised outcome measures into their practice (King et al., 2011; Wedge et 255 
al., 2012). In contrast to these findings, in the current study, the neonatal physiotherapy role 256 
is an advanced clinical sub-speciality that requires a relevant postgraduate education and an 257 
appropriate professional experience (Brady and Smith, 2015), and physiotherapists with 258 
greater years of experience of using the tools, were more likely to implement standardised 259 
outcome measures on their neonatal unit. In addition, there is a difference between using a 260 
developmental outcome measure to track or anticipate changes over time, and using a 261 
short-term outcome measure to evaluate the effectiveness of a single treatment or course of 262 
treatments. As a result, the use of ‘informal outcomes’ by expert practitioners in other non-263 
neonatal specialties may reflect the use of the outcome tools for a different purpose. In 264 
neonatal care, the tracking of development over a longer period may demand a more 265 
standardised approach. 266 
The most frequently used outcome measures were HNNE/HINE, GMs and LAPI. These 267 
tests, which have a discriminative and predictive function, evaluate posture, tone and the 268 
quality of movements in premature infants. The main differences are related to the 269 
administration time, infant handling involvement, equipment and training requirements (Kant, 270 
2013). The tendency of utilising more than two outcome measures (67.7%, n=23/34), 271 
confirms the need for further studies to evaluate whether the concurrent use of those tools 272 
would increase the ability to detect or discriminate typically developing preterm infants to 273 
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ensure the resources are targeted. In addition, size of caseload or local trust policies could 274 
be influencing factors in outcome measure preference and frequency of use, since Ronan 275 
and Barron (2012) identified that 39% of level 2 and 3 units (n=22/57, excluding 13 units that 276 
did not offer a neonatal physiotherapy service) had an ad hoc service, which was offered 277 
after a direct referral only. 278 
The overall positive attitude towards the use of outcome measures (39/43) and the strong 279 
consensus regarding the utility of outcome measures to provide insight for parents into their 280 
child’s physical functioning (39/43) differed from findings by King et al. (2011). Those authors 281 
suggested that paediatric physiotherapists perceived the utilisation of outcome measures to 282 
be less important to parents. King et al. (2011) undertook a thorough literature review 283 
regarding barriers and facilitators to outcome measure use in paediatric physiotherapy, 284 
summarising that the unwillingness of physiotherapists to utilise standardised measurements 285 
may be related to the incapacity of those tools to detect small changes in children with 286 
physical and developmental disabilities. Thus, they preferred an individualised approach that 287 
celebrated small achievements in order to maintain the children’s motivation and parents’ 288 
appreciation for long-term therapies. These differences between paediatric and neonatal 289 
fields might be related to the type of condition and care. Although both fields adopt a family-290 
centred approach, particular attention has been directed to parent-child interactions, parent 291 
education and early parent-administered physiotherapy on neonatal units in recent years 292 
(Ustad et al., 2016; Sweeney et al., 2009; Sweeney et al., 2010). In addition, the predictive 293 
nature of developmental tools might assume particular importance to parents at this early 294 
stage. 295 
High costs were described as significant limitations to the use of outcome measures on 296 
neonatal units, which reflected former findings from other physiotherapy specialist areas 297 
including musculoskeletal, neurological and paediatric fields (Jette et al., 2009; Wedge et al., 298 
2012; Van Peppen et al., 2008; King et al., 2011). Moreover, finding the opportune moment 299 
for outcome measure use was perceived as a barrier by the majority of respondents 300 
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(81.4%). From the literature, it seems that this limitation is specific to the neonatal setting 301 
and might partially explain the physiotherapists’ tendency to integrate different tools, some of 302 
which involve purely observational assessment, into the neonatal assessment. 303 
Significant differences were found between those physiotherapists that used outcome 304 
measures and those that did not. In particular, there was strong consensus among 305 
respondents who used outcome measures that they ‘fit into the way of working on units’ 306 
(94.1%) and are a ‘starting point for physiotherapy intervention and further referrals’ (94.1%).  307 
There were also significant differences between respondents using outcome measures and 308 
those not, in terms of the level of support offered by fellow physiotherapists and other 309 
professionals.  Those respondents using outcome measures felt significantly more 310 
supported by their colleagues and peers, (p<0.001 and p=0.005 for therapists and other 311 
professionals respectively). As opposed to former studies, which identified culture and 312 
organisation as determining factors in outcome measure implementation (Jette et al., 2009; 313 
King et al., 2001; Wedge et al., 2012), interdisciplinary support assumed significant 314 
importance in the neonatal physiotherapy field. This suggests that where a supportive 315 
environment exists, physiotherapists feel comfortable utilising outcome measures. 316 
It is acknowledged that this survey has several limitations. The non-standardised term, 317 
‘developmental outcome measure’, was utilised to group different neurological, behavioural 318 
or motor performance tests, since they assess various areas of neonatal development and 319 
they were designed for serial/longitudinal use to track the developmental evolution of infants 320 
(Brazelton and Nugent, 2011; Dubowitz et al., 1999; Einspieler, 2004, Lacey, 2004). The 321 
lack of consensus regarding this terminology may have impacted on the interpretation of 322 
questions and statements, leading to ambiguity of findings. There were a significant number 323 
of non-responses to certain individual items, which could have impacted on the validity of 324 
findings. These may have been reduced with a longer piloting process. However, the study 325 
was undertaken within the context of a fairly limited time-frame and the findings remain a 326 
useful addition to the literature. The use of an electronic survey may explain some of the 327 
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problems in completeness, consistency and a lower response rate compared to the 328 
epistolary method (Bethlehem, 2009; Ritter et al., 2004; Sivo et al., 2006). However, given 329 
that neonatal physiotherapy is a fairly small subspecialty, the response rate was deemed to 330 
be sufficient and representative of this group.  331 
Conclusion 332 
The results of this study suggest that outcome measures are commonly used by neonatal 333 
physiotherapists in the UK. The most frequently used outcome measures were HNNE/HINE, 334 
GMS and LAPI. There was generally a positive attitude towards outcome measure usage, 335 
but with some barriers to their implementation including the high cost. The non-use of 336 
outcome measures could be attributed to the level of expertise, type of training and a lack of 337 
interdisciplinary support. This provides a useful discussion point for experts in the field, when 338 
considering the impact that staff development and support could have on outcome measure 339 
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Table 1: Summary of participants 461 









Highest level of neonatal care provided 
 
   
 1 4 (12%) 0 4 (9%)  
 2 8 (24%) 4 (44%) 12 (28%) U = 110.5 
p = 0.177 
 3 17 (50%) 2 (22%) 19 (44%)  
 Other 1 (3%) 1 (11%) 2 (5%) 
 Not reported 4 (12%) 2 (22%) 6 (14%) 
      
Physiotherapy band levels present on the neonatal unit 
 
  
 Band 6 1 (3%) 1 (11%) 2 (5%) 
U = 132.5 
p = 0.513 
 Band 7 15 (44%) 2 (22%) 17 (40%) 
 Band 8 3 (9%) 0 3 (7%) 
 Bands 6 & 7 12 (35%) 5 (56%) 17 (40%) 
 Bands 6 & 8 1 (3%) 0 1 (2%) 
 Bands 7 & 8 1 (3%) 0 1 (2%) 
 Bands 5, 6 & 7 0 1 (11%) 1 (2%) 
 Bands 4, 6, 7 & 8 1 (3%) 0 1 (2%) 
 
Number of years using developmental outcome measures 
 
 no years 0 3 (33%) 3 (7%) U = 90 
p = 0.041  < 2 years 6 (18%) 2 (22%) 8 (19%) 
 2-5 years 9 (26%) 1 (11%) 10 (23%) 
 > 5 years 19 (56%) 3 (33%) 22 (51%)  
      
Training received in the use of developmental outcome measures 
 
 
 Yes 30 (88%) 3 (33%) 33 (77%) 
p = 0.002 
 No 4 (12%) 6 (67%) 10 (23%) 
      
Whether therapists have read the APCP competence framework for working in neonatal 
care  
 Yes 31 (91%) 8 (89%) 39 (91%) 
p = 1.00 
 No 3 (9%) 1 (11%) 4 (9%) 
OMs: developmental outcome measures; APCP: Association for Paediatric Chartered 462 








Table 2: Frequency of the use of developmental outcome measures 469 
OMs: developmental outcome measures; HNNE/HINE: Hammersmith Neonatal Neurological 470 
Examination/Hammersmith Infant Neurological Examination; GMs: Prechtl’s Method of Qualitative 471 
Assessment of General Movements; LAPI: Lacey Assessment of Preterm Infants; NBAS: Brazelton 472 
Neonatal Behavioural Assessment Scale; NIDCAP: Newborn Individualised Care and Assessment 473 
Program; TIMP: Test of Infant Motor Performance; NAPI: Neurobehavioural Assessment of the 474 
Preterm Infant; AIMS: Alberta Infant Motor Scale; Bayley: Bayley Scales of Infant and Toddler 475 
Development 476 
















HNNE/HINE 4 (11.8%) 4 (11.8%) 4 (11.8%) 4 (11.8%) 12 (35.3%) 28 (82.4%) 
GMs  5 (14.7%) 3 (8.8%) 1 (3%) 6 (17.6%) 12 (35.3%) 27 (79.4%) 
LAPI 8 (23.5%) 2 (5.9%) 1 (3%) 1 (3%) 14 (41.2%) 26 (76.5%)  
NBAS 11 (32.4%) 7 (20.6%) 1 (3%) 0 3 (8.8%) 22 (64.7%)  
NIDCAP 17 (50%) 0 0 1 (3%) 2 (5.9%) 20 (58.8%) 
TIMP 17 (50%) 1 (3%) 0 0 0 18 (53%)  
NAPI 19 (55.9%) 0 0 0 0 19 (55.9%)  
Others: AIMS 0   0 0 0 5 (14.7%) 5 (14.7%)  
Others: Bayley 0 2 (5.9%) 0 0 1 (3%) 3 (8.8%)  
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Table 3: Summary of barriers and facilitators questionnaire section 























8. I feel that I have a positive attitude towards 
the use of developmental outcome measures 
























U = 115 
p = 0.208 
9. The use of a developmental outcome measure 
fits into my way of working at my unit 
























U = 18.5 
p < 0.001 
10. I regard the use of a developmental outcome 
measure to be a good starting point for my 
physiotherapy interventions and for further 
referrals 
























U = 46 
p < 0.001 
11. It is important that developmental outcome 
measures can be used before 38-40 weeks 
postmenstrual age 
























U = 117 
p = 0.246 
12. I consider that a complex layout of a 
developmental outcome measure can be an 
obstacle to using it 
























U = 145.5 
p = 0.804 
13. The need for additional equipment (such as a 
video camera) can be an obstacle to using the 
developmental outcome measure in my unit 
























U = 123.5 
p = 0.35 
14. The number of items that require infant 
handling can be an obstacle to using a 
developmental outcome measure 
























U = 96 
p = 0.067 
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15. I feel that the use of developmental outcome 
measures can be too time-consuming 
























U = 108 
p = 0.15 
16. The cost of acquiring certain developmental 
outcome measures (such as courses and 
materials) can be an obstacle to using them 
























U = 124.5 
p = 0.341 
17. It is difficult to understand the use of 
developmental outcome measures in patients who 
seem healthy 
























U = 120 
p = 0.281 
18. Finding the right moment (such as infant 
awake) for the developmental assessment is often 
challenging 
























U = 148 
p = 0.863 
19. The use of developmental outcome measures 
in neonatal units is too stressful for the infant 
























U = 127.5 
p = 0.399 
20. Developmental outcome measures can be 
adapted to the individual needs of the infants 
























U = 79.5 
p = 0.016 
21. Developmental outcome measures give 
parents an insight into their child’s physical 
functioning 
























U = 96 
p = 0.055 
22. Fellow neonatal physiotherapists 
cooperate in applying the developmental 
outcome measures 
























U = 34 
p < 0.001 
23. Other professionals support the use of 
















U = 70 
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[Barrier (1)  Facilitator (5)] 
 
No 2 (22.2%) 1 (11.1%) 2 (22.2%) 3 (33.3%) 1 (11.1%) 9 (100%) p = 0.005 
24. Managers/directors support the use of 
developmental outcome measures 























U = 92.5 
p = 0.053 
OMs: developmental outcome measures 





Appendix 1: Questionnaire 
Developmental outcome measures 
Following are a couple of questions about the utilisation of developmental outcome measurement. 
1. Do you currently use a developmental 
outcome measure on your unit? 
☐Yes 
☐No: Please go to question number 4 
2. How often have you used the following 
developmental outcome measures? 
 
If you use other developmental outcome 





































Brazelton Neonatal Behavioural 












Neurobehavioural Assessment of the 












Newborn Individualised Care and 












Prechtl’s Method of Qualitative 
























































Other/further comments  
3. What is the youngest postmenstrual age 
range (weeks) that you would assess a 
baby using a developmental outcome 
measure? 
 
(please add additional comments in the box 
provided) 
 











4. If it were possible, which outcome 
measure/s would you like to introduce 
 
(tick all that apply on the list) 
 
 
☐Hammersmith Infant Neurological 
Examination (Dubowitz or NANI)  
☐Lacey Assessment of Preterm Infants (LAPI) 
☐Brazelton Neonatal Behavioural Assessment 
Scale (NBAS) 
☐Neurobehavioural Assessment of the 
preterm Infant (NAPI) 
☐Newborn Individualised Care and 
Assessment Program (NIDCAP) 
☐Prechtl’s Method of Qualitative Assessment 
of General Movements (GMs) 
☐Test of Infant Motor Performance (TIMP) 
☐I don’t know 
☐None 
☐Other: Please Specify ……… 
 
Other/further comments: 
5. What is your level of experience with the 
use of developmental outcome measures 
☐I have no experience 
☐<2 years of experience 
☐2-5 years of experience 
☐>5 years of experience 
 
Other/further comments: 
6. Have you received training in the use of 




Please state the outcome measure/s that you 
have been trained to use, and the type of 
training that you undertook (e.g. inservice 





Barriers and facilitators to the implementation of tests of infant development  
The Association of Paediatric Chartered Physiotherapists (APCP) published on 2011 and updated on 
2015 “A Competence Framework and Evidenced-Based Practice Guidance for the Physiotherapist 
working in the Neonatal Intensive Care and Special Care Unit in the United Kingdom”, in which is 
recommended the use of developmental outcome measures. 
 
7. Which of the following statement is true? ☐I read the APCP guidance 
☐I am aware of the APCP guidance, but I 
have not read them yet 





Following are a couple of statements about the use of developmental outcome measures. We would 
like to know whether you agree with the statement or not and in what degree. If you do not have a 
strong opinion, please try to find out if it is more like ‘agree’ or more like ‘disagree’. If you really do not 













8. I feel that I have a positive 
attitude towards the use of 
developmental outcome 
measures 
☐ ☐ ☐ ☐ ☐ 
9. The use of developmental 
outcome measures fits into 
my way of working at my 
unit 
☐ ☐ ☐ ☐ ☐ 
10. I regard the use of a 
developmental outcome 
measure to be a good 
starting point for my 
physiotherapy interventions 
and for further referrals 
 
Other/further comments: 
☐ ☐ ☐ ☐ ☐ 
 
11. It is important that 
developmental outcome 
measures can be used 




☐ ☐ ☐ ☐ ☐ 
12. I consider that a complex 
lay-out of a developmental 
outcome measure can be an 
obstacle to using it 
 
Other/further comments: 
☐ ☐ ☐ ☐ ☐ 
13. The need for additional 
equipment (such as a video 
camera) can be an obstacle 
to using the developmental 




☐ ☐ ☐ ☐ ☐ 
14. The number of items that 
require infant handling can 





☐ ☐ ☐ ☐ ☐ 
15. I feel that the use of 
developmental outcome 




☐ ☐ ☐ ☐ ☐ 
16. The cost of acquiring 
certain developmental 
outcome measures (such as 
courses and materials) can 
be an obstacle to using them 
 
Other/further comments: 
☐ ☐ ☐ ☐ ☐ 
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17. It is difficult to 
understand the use of 
developmental outcome 




☐ ☐ ☐ ☐ ☐ 
18. Finding the right moment 
(such as infant awake) for 
the developmental 




☐ ☐ ☐ ☐ ☐ 
19. The use of 
developmental outcome 
measures in neonatal units 




☐ ☐ ☐ ☐ ☐ 
20. Developmental outcome 
measures can be adapted to 




☐ ☐ ☐ ☐ ☐ 
21. Developmental outcome 
measures give parents an 




☐ ☐ ☐ ☐ ☐ 
22. Fellow neonatal 
physiotherapists cooperate 





☐ ☐ ☐ ☐ ☐ 
23. Other professionals 





☐ ☐ ☐ ☐ ☐ 
24. Managers/directors 















Neonatal physiotherapy service provision and training  
Following are a couple of questions about your neonatal physiotherapy service and training. 
25. What is the name of the hospital in which 
you work? 
 
This question is to account for multiple 
responses from the same unit. The name of 
the unit will NOT be revealed in the analysis 
or dissemination of findings 
 
 How many beds does your neonatal unit 




26. Level 1: 
27. Level 2: 
28. Level 3: 
 
Other/further comments: 
29. What bands of physiotherapy staff work on 
the neonatal unit? 
 





☐Band 3 assistant 






Please specify approximately how many 
hours per week your physiotherapy team 
spends on the neonatal unit: 
30. Where does your physiotherapy input 
come from? 
 










physiotherapists from acute trust 
 
☐Predominantly adult or general 
physiotherapists from acute trust 
 




31. What types of physiotherapy interventions 
are your neonatal physiotherapists 
involved with? 
 
(tick all that apply) 
☐Neuro-developmental evaluation  
☐Neuro-developmental interventions 
☐Respiratory / chest clearance 
☐Orthopaedic – e.g. OBPP, Talipes 
(Obstetric Brachial Plexus Palsy) 
☐Psychosocial meetings 






32. As a neonatal physiotherapist, what 
specialist training and support have you 
undertaken? 
 
(tick all that apply) 
☐I am a member of APCP (Association of 
Paediatric Chartered Physiotherapists) 
neonatal group 
☐I have attended courses related to 
neonatal care 
☐I have undertaken postgraduate 
education, which included neonatal care 
☐I have been involved in peer learning and 
support within the trust 
☐I have received teaching/training from 
senior colleagues 
☐I have undertaken my own self-directed 
learning 
☐Other (please state) 
 
